GlassScriptPhysician profile
Marilyn Kelleher
NPI 1932515582
$3,703.49
in general payments reported to CMS, 2019-2025
26 companies · $607 in 2025
The $607 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $655 · 2021: $347 · 2022: $627 · 2023: $575 · 2024: $893 · 2025: $607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,010 · Education: $65.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,010.13 |
| Education | $65.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $708.20 | 2020-2025 | |
| Axonics, INC. | $509.30 | 2021-2024 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $464.85 | 2023-2025 | Gemtesa |
| Boston Scientific Corporation | $436.04 | 2021-2024 | Solyx Sis System, Lynx System, Ams 700 |
| Medtronic, INC. | $290.71 | 2023-2025 | Interstim |
| Astellas Pharma US INC | $231.16 | 2020-2023 | Myrbetriq |
| Urogen Pharma, INC. | $160.21 | 2020-2025 | |
| Dendreon Pharmaceuticals LLC | $153.55 | 2020-2023 | Provenge |
| Cook Medical LLC | $142.98 | 2022 | |
| Procept Biorobotics Corporation | $90.62 | 2024 | Aquabeam System |
| Abbvie INC. | $68.48 | 2020-2025 | |
| Olympus America INC. | $68.33 | 2022-2025 | Itind System, Uretero-Reno Videoscope, Cysto-Nephro Videoscope |
| Ferring Pharmaceuticals INC. | $62.17 | 2025 | Adstiladrin |
| Endo USA, INC. | $56.85 | 2024-2025 | Xiaflex |
| Pfizer INC. | $56.59 | 2021-2024 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $26.39 | 2025 | Gentlecath |
| Blue Earth Diagnostics | $23.04 | 2025 | Posluma |
| Rochester Medical Corporation | $22.52 | 2021 | |
| Allergan, INC. | $19.40 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.59 | 2024 | |
| Progenics Pharmaceuticals, INC. | $16.66 | 2025 | |
| Medtronic USA, INC. | $16.62 | 2020 | |
| Novartis Pharmaceuticals Corporation | $16.22 | 2020 | |
| Photocure INC | $15.87 | 2024 | Cysview |
| Laborie Medical Technologies Corp. | $15.00 | 2025 | |
| Janssen Biotech, INC. | $13.14 | 2024 | Erleada |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marilyn Kelleher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.